DexCom Market Sentiment

DexCom Inc

DXCMNASDAQ

Trade with Public

$79.67

-0.59-0.74%

마지막 업데이트: Oct 22, 9:29 AM

$79.67

-0.59-0.74%

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 옵션 주식 보고서

실적: Q3 2026 실적이 목 10월 29th에 시장 마감 후 7일 후 후에 발표됩니다.

컨퍼런스 콜: 7일 후 4:30 오후에 컨퍼런스 콜이 예정되어 있습니다.

웹캐스트를 보려면 클릭하세요.

DexCom Market Sentiment - Benzinga

DexCom Market Sentiment

Market sentiment signals for DexCom (DXCM): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 4.3% short float

Options Flow▼ 2.60 P/C ratio

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

30 analysts

Options Flow (P/C)

2.60

More puts — Bearish

395 calls · 1,028 puts

Avg Consensus PT

$91

+14.5%

Highest Price Target

$115

+44.3%

Redburn Atlantic

Lowest Price Target

$64

-19.7%

Barclays

Short Interest

4.3%

Declining — Bullish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 12, 2026	BTIG	Ryan Zimmerman—	+20.5%	$90 → $96	Maintained	Buy
Oct 7, 2026	Barclays	Christopher Pasquale—	+44.3%	$115	Initiate	Overweight
Oct 1, 2026	RBC Capital	Kendall Au—	+31.8%	$90 → $105	Maintained	Outperform
Sep 18, 2026	Truist Securities	Richard Newitter—	+28.0%	$93 → $102	Maintained	Buy
Sep 18, 2026	TD Cowen	Joshua Jennings—	+19.2%	$95 → $95	Maintained	Buy
Aug 4, 2026	Argus Research	Steve Silver—	+20.5%	$86 → $96	Maintained	Buy
Aug 3, 2026	Canaccord Genuity	William Plovanic—	+13.0%	$82 → $90	Maintained	Buy
Jul 31, 2026	Citigroup	Joanne Wuensch—	+10.5%	$84 → $88	Maintained	Buy
Jul 31, 2026	RBC Capital	Kendall Au—	+13.0%	$85 → $90	Maintained	Outperform
Jul 31, 2026	Mizuho	Anthony Petrone—	+19.2%	$90 → $95	Maintained	Outperform
Jul 31, 2026	JP Morgan	Robbie Marcus—	+2.9%	$65 → $82	Maintained	Neutral
Jul 31, 2026	Piper Sandler	Matt O'Brien—	+19.2%	$88 → $95	Maintained	Overweight
Jul 31, 2026	Wells Fargo	Larry Biegelsen—	+13.0%	$85 → $90	Maintained	Overweight
Jul 31, 2026	Stifel	Jonathan Block—	+19.2%	$90 → $95	Maintained	Buy
Jul 31, 2026	Benchmark	Bruce D. Jackson—	+2.9%	$77 → $82	Maintained	Buy
Jul 31, 2026	Truist Securities	Richard Newitter—	+16.7%	$87 → $93	Maintained	Buy
Jul 31, 2026	BTIG	Marie Thibault—	+13.0%	$80 → $90	Maintained	Buy
Jul 28, 2026	UBS	Patrick Wood—	+20.5%	$96	Reinstates	Buy
Jul 16, 2026	Truist Securities	Richard Newitter—	+9.2%	$80 → $87	Maintained	Buy
Jul 15, 2026	Mizuho	Anthony Petrone—	+13.0%	$85 → $90	Maintained	Outperform
Jun 23, 2026	Deutsche Bank	Kieran Ryan—	+7.9%	$86	Initiate	Buy
Jun 15, 2026	Piper Sandler	Matt O'Brien—	+10.5%	$75 → $88	Maintained	Overweight
Jun 10, 2026	TD Cowen	Joshua Jennings—	+19.2%	$75 → $95	Maintained	Buy
Jun 9, 2026	Mizuho	Anthony Petrone—	+6.7%	$75 → $85	Maintained	Outperform
Jun 5, 2026	Stifel	Jonathan Block—	+13.0%	$85 → $90	Maintained	Buy

More with Benzinga EdgeGet Access

Insider & Market Activity News

Decoding DexCom's Options Activity: What's the Big Picture?

Benzinga Insights

PRO
DexCom Option Alert: Nov 7 $71 Calls At The Ask: 3000 @ $2.79 Vs 1 OI; Earnings 10/30 After Close Ref=$65.735

Benzinga Newsdesk

Spotlight on DexCom: Analyzing the Surge in Options Activity

Benzinga Insights

Check Out What Whales Are Doing With DXCM

Benzinga Insights

The End Of The Diabetes Industry? This Small Cap Could Upend The Business Models of Pharma Giants

is it the end of the diabetes industry? Here's a small cap that could upend the business models of pharma giants...

David Pinsen

DexCom's Options: A Look at What the Big Money is Thinking

Benzinga Insights

DexCom Inc

뉴스

파트너 / 기고자

벤징가 글로벌

DexCom Market Sentiment

Bulls vs Bears

Key Signals

Recent Analyst Actions

Insider & Market Activity News

Decoding DexCom's Options Activity: What's the Big Picture?

PRO
DexCom Option Alert: Nov 7 $71 Calls At The Ask: 3000 @ $2.79 Vs 1 OI; Earnings 10/30 After Close Ref=$65.735

Spotlight on DexCom: Analyzing the Surge in Options Activity

Check Out What Whales Are Doing With DXCM

The End Of The Diabetes Industry? This Small Cap Could Upend The Business Models of Pharma Giants

DexCom's Options: A Look at What the Big Money is Thinking

People Also Watch

Bulls vs Bears

People Also Watch

DexCom Inc

뉴스

파트너 / 기고자

벤징가 글로벌

DexCom Market Sentiment

Bulls vs Bears

Key Signals

Recent Analyst Actions

Insider & Market Activity News

Decoding DexCom's Options Activity: What's the Big Picture?

PRODexCom Option Alert: Nov 7 $71 Calls At The Ask: 3000 @ $2.79 Vs 1 OI; Earnings 10/30 After Close Ref=$65.735

Spotlight on DexCom: Analyzing the Surge in Options Activity

Check Out What Whales Are Doing With DXCM

The End Of The Diabetes Industry? This Small Cap Could Upend The Business Models of Pharma Giants

DexCom's Options: A Look at What the Big Money is Thinking

People Also Watch

Bulls vs Bears

People Also Watch

PRO
DexCom Option Alert: Nov 7 $71 Calls At The Ask: 3000 @ $2.79 Vs 1 OI; Earnings 10/30 After Close Ref=$65.735